Lagging Behind Regional Peers

The Croatian market is small and behind many of its regional neighbours, including Hungary, despite its relatively advanced status. At more than 70% by value, generics - comprising mostly relatively expensive branded generics - meet the bulk of demand for pharmaceuticals, with the segment continuing to be boosted by healthcare debts, cost-containment initiatives and the support for the strong domestic generics industry in the face of distinct intellectual property (IP) deficiencies.

To read the full article, please choose one of the following options: